Large-scale testing (Phase 3)Not Yet RecruitingNCT06841614What this trial is testingEBOla Post-Exposure ProphylaxisWho this might be right forEbola Virus Disease ANRS, Emerging Infectious Diseases 160
Testing effectiveness (Phase 2)WithdrawnNCT04268966What this trial is testingAn Open-Label Study , Safety and Tolerability of Brincidofovir for Post Exposure Prophylaxis of EbolaWho this might be right forEbola Virus Disease Jazz Pharmaceuticals
Testing effectiveness (Phase 2)Study completedNCT02329054What this trial is testingEfficacy of Favipiravir Against Ebola (JIKI)Who this might be right forEbola Virus Disease Institut National de la Santé Et de la Recherche Médicale, France 126
Post-approval studies (Phase 4)UnknownNCT06587503What this trial is testingSafety and Immunogenicity of rVSVΔG-ZEBOV-GP Vaccination When Dosed Concurrently With mRNA COVID-19 Vaccine Booster DosesWho this might be right forEbola Virus DiseaseCOVID-19 University of Birmingham 72
Early research (Phase 1)Study completedNCT00374309What this trial is testingExperimental Vaccine for Prevention of Ebola Virus InfectionWho this might be right forEbola Hemorrhagic FeverEbola Virus DiseaseEbola Virus Vaccines+2 more National Institute of Allergy and Infectious Diseases (NIAID) 48
Early research (Phase 1)Study completedNCT03800173What this trial is testingEvaluate the Single Dose Safety, Tolerability and Pharmacokinetics of IV BCX4430Who this might be right forMarburg Virus Disease BioCryst Pharmaceuticals 32
Testing effectiveness (Phase 2)Study completedNCT04711356What this trial is testingAd26.ZEBOV Booster in Children Previously Vaccinated With Ad26.ZEBOV and MVA-BN-Filo (EBOVAC Booster Study)Who this might be right forEbola Virus Disease London School of Hygiene and Tropical Medicine 50
Early research (Phase 1)Study completedNCT04723602What this trial is testingEvaluation of Safety, Tolerability and Immune Responses of Ebola-S and Marburg Vaccines in Healthy AdultsWho this might be right forEbola Virus DiseaseMarburg Virus Disease Albert B. Sabin Vaccine Institute 32
Early research (Phase 1)Study completedNCT03478891What this trial is testingSafety and Pharmacokinetics of a Human Monoclonal Antibody, VRC-EBOMAB092-00-AB (MAb114), Administered Intravenously to Healthy AdultsWho this might be right forHealthy Adult Immune Responses to Vaccine National Institute of Allergy and Infectious Diseases (NIAID) 19
Not applicableStudy completedNCT04815174What this trial is testingObservational Study of the Clinico-biological Evolution and Standard of Care Offered to Patients With Ebola Virus DiseaseWho this might be right forEbola Virus Disease Alliance for International Medical Action 711
Testing effectiveness (Phase 2)Study completedNCT03333538What this trial is testingRandomized Placebo-controlled Study of Safety and Immunogenicity of GamEvac-LyoWho this might be right forHealthy Volunteers Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation 220
Testing effectiveness (Phase 2)Study completedNCT03031912What this trial is testingAfrican-Canadian Study of HIV-Infected Adults and a Vaccine for Ebola - ACHIV-EbolaWho this might be right forEbola Canadian Immunization Research Network 251
Early research (Phase 1)Study completedNCT02319772What this trial is testingEvaluate the Safety, Tolerability and Pharmacokinetics of BCX4430Who this might be right forFilovirus InfectionsEbola Virus Infection BioCryst Pharmaceuticals 94
Early research (Phase 1)Study completedNCT02464670What this trial is testingOpen-Label Study of INO-4212 With or Without INO-9012, Administered IM or ID Followed by Electroporation in Healthy VolunteersWho this might be right forEbola Vaccine Inovio Pharmaceuticals 240
Early research (Phase 1)Study completedNCT03428347What this trial is testingAn Open Study of the Safety and Pharmacokinetics of a Medicinal Product for Emergency Prevention of EbolaWho this might be right forHealthy Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation 25
Testing effectiveness (Phase 2)Study completedNCT04385719What this trial is testingDrug-drug Interactions Between Remdesivir and Commonly Used Antiretroviral TherapyWho this might be right forEbolaHIV/AIDS Makerere University 24
Early research (Phase 1)Study completedNCT02283099What this trial is testingPhase I Trial to Assess the Safety, Tolerability and Immunogenicity of a Ebola Virus Vaccine (rVSVΔG-ZEBOV-GP)Who this might be right forHemorrhagic Fever, Ebola Universitätsklinikum Hamburg-Eppendorf 30
Testing effectiveness (Phase 2)Study completedNCT02363322What this trial is testingPutative Investigational Therapeutics in the Treatment of Patients With Known Ebola InfectionWho this might be right forEbola Virus Infection National Institute of Allergy and Infectious Diseases (NIAID) 72
Testing effectiveness (Phase 2)Study completedNCT02289027What this trial is testingA Clinical Trial on the Candidate Vaccine cAd3-EBOZ in Healthy Adults in SwitzerlandWho this might be right forEbola Vaccines Centre Hospitalier Universitaire Vaudois 120
Not applicableUnknownNCT06093646What this trial is testingAddressing Medium- to Long-term EBOLA Associated Psychological Distress and Psychosocial Problems in Central UgandaWho this might be right forEbola Virus Disease MRC/UVRI and LSHTM Uganda Research Unit 1,000